GLUE Institutional Ownership & Shareholders

MONTE ROSA THERAPEUTICS INC (GLUE) is currently held by 191 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $2.22B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

Price T Rowe Associates Inc is currently the largest disclosed institutional shareholder of GLUE tracked by InsiderSet, reporting ownership valued at approximately $214.44M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $94.19M, representing an estimated loss of -56.07% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 57% of the total disclosed GLUE value among the investors covered in this analysis. Major shareholders include Price T Rowe Associates Inc, Nea Management Company, Llc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in MONTE ROSA THERAPEUTICS INC (GLUE).

This page ranks the largest institutional GLUE shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

191

Total Reported Value

$2.22B

Largest Holder

Price T Rowe Associates Inc

Largest Position

$214.44M

Insider Transactions (90d)

1

Latest Filing Quarter

Q2 2026

New Institutional Positions

63

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Price T Rowe Associates Inc0.02%8,861,171$214,442,000$94,194,248-$120,247,752-56.07%
Nea Management Company, Llc11.72%7,692,298$186,153,612$81,769,128-$104,384,484-56.07%
Blackrock, Inc.0.00%6,843,087$165,602,706$72,742,015-$92,860,691-56.07%
Tcg Crossover Management, Llc2.69%4,622,151$111,856,054$49,133,465-$62,722,589-56.07%
Vestal Point Capital, Lp2.60%4,600,000$111,320,000$48,898,000-$62,422,000-56.07%
Bvf Inc/Il2.76%4,460,886$107,953,441$47,419,218-$60,534,223-56.07%
Baker Bros. Advisors Lp0.53%4,345,736$105,166,811$46,195,174-$58,971,637-56.07%
State Street Corp0.00%3,731,416$90,300,267$39,664,952-$50,635,315-56.07%
Suvretta Capital Management, Llc1.81%3,549,539$85,898,844$37,731,600-$48,167,244-56.07%
Vanguard Capital Management Llc0.00%3,412,927$82,592,833$36,279,414-$46,313,419-56.07%
Versant Venture Management, Llc47.34%3,180,780$76,974,876$33,811,691-$43,163,185-56.07%
Braidwell Lp2.19%2,451,562$59,327,800$26,060,104-$33,267,696-56.07%
Geode Capital Management, Llc0.00%1,864,113$45,121,645$19,815,521-$25,306,124-56.08%
American Century Companies Inc0.02%1,622,846$39,272,873$17,250,853-$22,022,020-56.07%
Marshall Wace, Llp0.03%1,593,600$38,565,119$16,939,968-$21,625,151-56.07%
Aisling Capital Management Lp7.98%1,555,664$37,647,069$16,536,708-$21,110,361-56.07%
Bellevue Group Ag0.61%1,190,000$28,798,000$12,649,700-$16,148,300-56.07%
Dimensional Fund Advisors Lp0.01%1,177,488$28,493,337$12,516,697-$15,976,640-56.07%
Mpm Bioimpact Llc1.71%1,161,081$28,098,160$12,342,291-$15,755,869-56.07%
Silverarc Capital Management, Llc2.98%1,108,295$26,820,739$11,781,176-$15,039,563-56.07%
Frazier Life Sciences Management, L.P.0.53%1,000,000$24,200,000$10,630,000-$13,570,000-56.07%
Goldman Sachs Group Inc0.00%998,253$24,157,723$10,611,429-$13,546,294-56.07%
Woodline Partners Lp0.07%962,884$23,301,793$10,235,457-$13,066,336-56.07%
Fmr Llc0.00%934,414$22,612,829$9,932,821-$12,680,008-56.07%
Vanguard Portfolio Management Llc0.00%791,932$19,164,754$8,418,237-$10,746,517-56.07%
Morgan Stanley0.00%789,545$19,106,990$8,392,863-$10,714,127-56.07%
Nextech Invest, Ltd.0.87%761,153$18,419,903$8,091,056-$10,328,847-56.07%
Opaleye Management Inc.1.63%745,000$18,029,000$7,919,350-$10,109,650-56.07%
Northern Trust Corp0.00%652,087$15,780,505$6,931,685-$8,848,820-56.07%
Nantahala Capital Management, Llc0.95%651,993$15,778,231$6,930,686-$8,847,545-56.07%
First Trust Advisors Lp0.01%647,796$15,676,663$6,886,071-$8,790,592-56.07%
Charles Schwab Investment Management Inc0.00%616,310$14,914,702$6,551,375-$8,363,327-56.07%
Boone Capital Management Llc3.48%615,287$14,889,945$6,540,501-$8,349,444-56.07%
Bridgeway Capital Management, Llc0.24%552,566$13,372,097$5,873,777-$7,498,320-56.07%
Aqr Capital Management Llc0.00%520,648$12,599,682$5,534,488-$7,065,194-56.07%
Vanguard Fiduciary Trust Co0.00%505,500$12,233,100$5,373,465-$6,859,635-56.07%
Parkwood Llc0.88%505,000$12,221,000$5,368,150-$6,852,850-56.07%
Janus Henderson Group Plc0.01%685,926$11,293,772$7,291,393-$4,002,379-35.44%
Adage Capital Partners Gp, L.L.C.0.02%450,000$10,890,000$4,783,500-$6,106,500-56.07%
Kennedy Capital Management Llc0.17%405,529$9,813,802$4,310,773-$5,503,029-56.07%
Ameriprise Financial Inc0.00%383,335$9,276,708$4,074,851-$5,201,857-56.07%
Alphabet Inc.0.01%372,474$9,013,871$3,959,399-$5,054,472-56.07%
Fisher Asset Management, Llc0.00%363,520$8,797,182$3,864,218-$4,932,964-56.07%
Allspring Global Investments Holdings, Llc0.01%352,857$8,539,139$3,750,870-$4,788,269-56.07%
Empowered Funds, Llc0.04%329,266$7,968,237$3,500,098-$4,468,139-56.07%
Duquesne Family Office LlcStanley Druckenmiller0.17%297,600$7,202,000$3,163,488-$4,038,512-56.07%
Td Asset Management Inc0.01%285,936$6,919,651$3,039,500-$3,880,151-56.07%
Bank Of America Corp0.00%254,561$6,160,376$2,705,983-$3,454,393-56.07%
Bank Of New York Mellon Corp0.00%222,521$5,385,007$2,365,398-$3,019,609-56.07%
Longaeva Partners L.P.0.15%216,792$5,246,366$2,304,499-$2,941,867-56.07%
Showing 50 of 191

Frequently asked questions about GLUE

  • Who are the largest institutional holders of GLUE?

    The largest institutional holders of GLUE reported in the latest SEC Form 13F filings include Price T Rowe Associates Inc, Nea Management Company, Llc, Blackrock, Inc., Tcg Crossover Management, Llc, and Vestal Point Capital, Lp. InsiderSet ranks institutional holders by their latest reported GLUE position.

  • What is GLUE institutional ownership?

    This page tracks GLUE positions reported by institutional investment managers through SEC Form 13F. MONTE ROSA THERAPEUTICS INC (GLUE) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own GLUE?

    InsiderSet currently tracks 191 institutional managers reporting GLUE holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of GLUE shareholders.

  • How much GLUE stock do institutions own?

    Institutional investment managers disclosed approximately $2.22B in GLUE holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was GLUE institutional ownership last updated?

    The latest GLUE institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional GLUE holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its GLUE position after the reporting date.

  • Are institutions buying or selling GLUE?

    Institutional buying and selling can be analyzed by comparing GLUE positions across consecutive 13F reporting periods. InsiderSet's GLUE Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View GLUE ownership changes.

  • How has GLUE institutional ownership changed over time?

    InsiderSet tracks GLUE institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.